Meet Our Team

Guyane, holding a master’s degree in Anthropology with a specialization in archaeology, exhibited rigor and meticulousness in her previous roles as an Archaeologist and Research Assistant before falling ill in 2021. Guyane serves on the Boards of Directors for the Association québécoise de l’encéphalomyélite myalgique (AQEM) and moderates COVID longue Québec Long COVID, a science-based support group for individuals grappling with Long COVID. Leveraging her expertise and personal experience, she is dedicated to providing people with accurate and secure information about their condition.

Guyane, holding a master’s degree in Anthropology with a specialization in archaeology, exhibited rigor and meticulousness in her previous roles as an Archaeologist and Research Assistant before falling ill in 2021. Guyane serves on the Boards of Directors for the Association québécoise de l’encéphalomyélite myalgique (AQEM) and moderates COVID longue Québec Long COVID, a science-based support group for individuals grappling with Long COVID. Leveraging her expertise and personal experience, she is dedicated to providing people with accurate and secure information about their condition.

Liimiiuum Hala’ayt (Singing Shaman) is two-spirit and of both Indigenous (Gitga’at – Ts’msyen) and Settler (Norwegian) background and is guided by the teachings of their ancestors. Their positive and personal cultural identity and knowledge have contributed to facilitating innovative and inclusive learning spaces in both K-12 and post-secondary education for over twenty-five years. Robert is passionate about learning and teaching; their commitment to improving the lives of those who they are in-service to is what drives them. This is evident in their approaches that honour: relationships, respect, reciprocity, relevance and responsibility. Robert is an active contributor to systemic transformation and provides guidance and consultation to many professional bodies and institutions.

Liimiiuum Hala’ayt (Singing Shaman) is two-spirit and of both Indigenous (Gitga’at – Ts’msyen) and Settler (Norwegian) background and is guided by the teachings of their ancestors. Their positive and personal cultural identity and knowledge have contributed to facilitating innovative and inclusive learning spaces in both K-12 and post-secondary education for over twenty-five years. Robert is passionate about learning and teaching; their commitment to improving the lives of those who they are in-service to is what drives them. This is evident in their approaches that honour: relationships, respect, reciprocity, relevance and responsibility. Robert is an active contributor to systemic transformation and provides guidance and consultation to many professional bodies and institutions.

Melissa Croskery, an Occupational Therapist with over 20 years of experience in Northern Canada, specializes in supporting children, youth, and their caregivers as well as teachers dealing with complex needs, such as neurodiversity and trauma. She was Regional Director of the North Chapter of the Canadian Association of Occupational Therapists for the past three years. Melissa also has lived experience with Long Covid and has worked in Northern Canada to support advocacy for those living with Post-Covid Condition, particularly those in rural and remote locations.

Melissa Croskery, an Occupational Therapist with over 20 years of experience in Northern Canada, specializes in supporting children, youth, and their caregivers as well as teachers dealing with complex needs, such as neurodiversity and trauma. She was Regional Director of the North Chapter of the Canadian Association of Occupational Therapists for the past three years. Melissa also has lived experience with Long Covid and has worked in Northern Canada to support advocacy for those living with Post-Covid Condition, particularly those in rural and remote locations.

Dr. Falcone is the Director of the IRCM Post-COVID-19 Research Clinic and Microbiome and Mucosal Defence Research Unit at the Montreal Clinical Research Institute (IRCM). She is an Assistant Clinical Professor at Université de Montréal, holding a Tier 2 Canada Research Chair in the Role of the Microbiome in Primary Immunodeficiency. As a pioneer during the pandemic, she established the first long COVID research clinic in Quebec, clinically evaluating hundreds of individuals with long COVID while investigating the pathophysiological mechanisms underlying post-COVID-19 conditions. Dr. Falcone actively contributes to provincial and federal long COVID initiatives, co-chaired Canada’s first long COVID research symposium, and plays leadership roles in several research committees and networks.

Dr. Falcone is the Director of the IRCM Post-COVID-19 Research Clinic and Microbiome and Mucosal Defence Research Unit at the Montreal Clinical Research Institute (IRCM). She is an Assistant Clinical Professor at Université de Montréal, holding a Tier 2 Canada Research Chair in the Role of the Microbiome in Primary Immunodeficiency. As a pioneer during the pandemic, she established the first long COVID research clinic in Quebec, clinically evaluating hundreds of individuals with long COVID while investigating the pathophysiological mechanisms underlying post-COVID-19 conditions. Dr. Falcone actively contributes to provincial and federal long COVID initiatives, co-chaired Canada’s first long COVID research symposium, and plays leadership roles in several research committees and networks.

Kimberly Flowers (B.Mgt.) is a champion of patient-empowered health care. She is a founding partner of the patient-led Head and Neck Cancer Support Society and involved in health research projects as a patient advocate, advisor and project-partner. Kimberly’s lived experience with post-Cancer and post-COVID conditions brings a unique lens to the project, in addition to her background in evaluation process and performance measures.

Kimberly Flowers (B.Mgt.) is a champion of patient-empowered health care. She is a founding partner of the patient-led Head and Neck Cancer Support Society and involved in health research projects as a patient advocate, advisor and project-partner. Kimberly’s lived experience with post-Cancer and post-COVID conditions brings a unique lens to the project, in addition to her background in evaluation process and performance measures.

Dr. Jessica Hopkins is a public health and preventive medicine physician with significant local and provincial public health expertise. As the Chief Health Protection and Emergency Preparedness Officer at Public Health Ontario, she leads a multi-disciplinary team in analyzing data and evidence to advise decision-makers on public health and infection control programs. Dr. Hopkins has previously served as the Medical Officer of Health (MOH) for Peel Region, Associate MOH in Hamilton and Niagara Region, and is a practicing family doctor. She is an Associate Professor at McMaster University and an Adjunct Lecturer at the Dalla Lana School of Public Health, University of Toronto.

Dr. Jessica Hopkins is a public health and preventive medicine physician with significant local and provincial public health expertise. As the Chief Health Protection and Emergency Preparedness Officer at Public Health Ontario, she leads a multi-disciplinary team in analyzing data and evidence to advise decision-makers on public health and infection control programs. Dr. Hopkins has previously served as the Medical Officer of Health (MOH) for Peel Region, Associate MOH in Hamilton and Niagara Region, and is a practicing family doctor. She is an Associate Professor at McMaster University and an Adjunct Lecturer at the Dalla Lana School of Public Health, University of Toronto.

David M. Kaplan MD, MSc, CCFP, FCFP is an associate professor in the Department of Family & Community Medicine and Joint Centre for Bioethics at the Temerty Faculty of Medicine at the University of Toronto.

Dr. Kaplan is an academic family physician at North York General Hospital, where he has served as the Deputy Chair of the Medical Advisory Committee and Chief of Family Medicine. Dr. Kaplan is the Vice-President, Quality at Ontario Health. He completed his graduate training in Health Policy and Bioethics in the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is a fellow of the College of Family Physicians of Canada.

David M. Kaplan MD, MSc, CCFP, FCFP is an associate professor in the Department of Family & Community Medicine and Joint Centre for Bioethics at the Temerty Faculty of Medicine at the University of Toronto.

Dr. Kaplan is an academic family physician at North York General Hospital, where he has served as the Deputy Chair of the Medical Advisory Committee and Chief of Family Medicine. Dr. Kaplan is the Vice-President, Quality at Ontario Health. He completed his graduate training in Health Policy and Bioethics in the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is a fellow of the College of Family Physicians of Canada.

Dr. Nieuwlaat is Associate Professor and Director of the Graduate Diploma in Clinical Epidemiology program in the Department of Health Research Methods, Evidence, and Impact at McMaster University. He is the Director of the Michael G. DeGroote Cochrane Canada Centre, researcher at the MacGRADE Centre, member of the GRADE Working Group, member of the Red Hat group for enhancing the update of course outcome sets, and program co-Director and steering committee member of the International Guideline Development Training & Certification Program (INGUIDE).

His research interest and expertise include health guideline development and systematic review methodology innovations, quality of care assessment, best practice implementation, core outcome sets, and patient medication adherence. He has served as a systematic review and guideline development methodology lead for multiple guidelines for the American Society of Hematology, Canadian Rheumatology Association, and Public Health Agency of Canada. Dr. Nieuwlaat is also a collaborator for the COVID-19 recommendation map.

Dr. Nieuwlaat is Associate Professor and Director of the Graduate Diploma in Clinical Epidemiology program in the Department of Health Research Methods, Evidence, and Impact at McMaster University. He is the Director of the Michael G. DeGroote Cochrane Canada Centre, researcher at the MacGRADE Centre, member of the GRADE Working Group, member of the Red Hat group for enhancing the update of course outcome sets, and program co-Director and steering committee member of the International Guideline Development Training & Certification Program (INGUIDE).

His research interest and expertise include health guideline development and systematic review methodology innovations, quality of care assessment, best practice implementation, core outcome sets, and patient medication adherence. He has served as a systematic review and guideline development methodology lead for multiple guidelines for the American Society of Hematology, Canadian Rheumatology Association, and Public Health Agency of Canada. Dr. Nieuwlaat is also a collaborator for the COVID-19 recommendation map.

Dr. Quinn, a General Internist and Palliative Care Clinician-Scientist at Sinai Health, focuses on enhancing end-of-life care for people with non-cancer terminal illnesses such as heart failure and dementia. As an Adjunct Scientist at ICES, he employs advanced analytic methods using administrative data to improve access and delivery of high-quality care. Dr. Quinn’s research also addresses the recognition and care of people with post-COVID-19 conditions. Recognized with the Governor General’s Gold Medal and the John Charles Polanyi Prize, he has published over 80 peer-reviewed articles in high-impact journals like JAMA and BMJ, along with securing over $27 million in grant funding.

Dr. Quinn, a General Internist and Palliative Care Clinician-Scientist at Sinai Health, focuses on enhancing end-of-life care for people with non-cancer terminal illnesses such as heart failure and dementia. As an Adjunct Scientist at ICES, he employs advanced analytic methods using administrative data to improve access and delivery of high-quality care. Dr. Quinn’s research also addresses the recognition and care of people with post-COVID-19 conditions. Recognized with the Governor General’s Gold Medal and the John Charles Polanyi Prize, he has published over 80 peer-reviewed articles in high-impact journals like JAMA and BMJ, along with securing over $27 million in grant funding.

Holger Schünemann is professor emeritus in the Departments of Medicine and of Health Research Methods, Evidence, and Impact at McMaster University, where he was department chair from 2009 to 2019. He graduated from the Medical School of Hannover (1993 & Dr.med. in 1994) and trained in lung biology, epidemiology, internal medicine and preventive medicine/public health at the University at Buffalo, State of New York (M.Sc. Epidemiology in 1997; Ph.D. Epidemiology & Community Medicine in 2000). He is co-chair of the GRADE working group and director the Humanitas University GRADE center. Maintaining an active internal medicine practice fulfills his passion for patient care and ensures his research is people oriented. He is an author of over 900 peer-reviewed publications and among the 15 most cited scientists in medicine in Canada.

Holger Schünemann is professor emeritus in the Departments of Medicine and of Health Research Methods, Evidence, and Impact at McMaster University, where he was department chair from 2009 to 2019. He graduated from the Medical School of Hannover (1993 & Dr.med. in 1994) and trained in lung biology, epidemiology, internal medicine and preventive medicine/public health at the University at Buffalo, State of New York (M.Sc. Epidemiology in 1997; Ph.D. Epidemiology & Community Medicine in 2000). He is co-chair of the GRADE working group and director the Humanitas University GRADE center. Maintaining an active internal medicine practice fulfills his passion for patient care and ensures his research is people oriented. He is an author of over 900 peer-reviewed publications and among the 15 most cited scientists in medicine in Canada.

Dr. Vohra is a clinician scientist and professor in the Faculty of Medicine & Dentistry at the University of Alberta. Her training includes pediatrics, clinical pharmacology, and clinical epidemiology. Her research program focuses on innovation in clinical research methods, including clinical trials and harms reporting; she has most often applied this to patient use of complementary therapies. Dr. Vohra co-leads a national team studying myalgic encephalomyelitis/chronic fatigue syndrome with and without associated Long COVID.

Dr. Vohra is a clinician scientist and professor in the Faculty of Medicine & Dentistry at the University of Alberta. Her training includes pediatrics, clinical pharmacology, and clinical epidemiology. Her research program focuses on innovation in clinical research methods, including clinical trials and harms reporting; she has most often applied this to patient use of complementary therapies. Dr. Vohra co-leads a national team studying myalgic encephalomyelitis/chronic fatigue syndrome with and without associated Long COVID.

Dr. Wadhwa is a pediatric infectious diseases staff physician and clinician educator at the Hospital for Sick Children (SickKids) in Toronto, Canada. She is medical lead of the SickKids Long COVID clinic and co-principal investigator of the Canadian Pediatric Surveillance Program (CPSP) post COVID-19 condition study. Dr. Wadhwa has been an invited expert on long COVID in children for the Ontario Science Table as well as the Chief Science Advisor of Canada Task Force on post COVID-19 condition.

Dr. Wadhwa is a pediatric infectious diseases staff physician and clinician educator at the Hospital for Sick Children (SickKids) in Toronto, Canada. She is medical lead of the SickKids Long COVID clinic and co-principal investigator of the Canadian Pediatric Surveillance Program (CPSP) post COVID-19 condition study. Dr. Wadhwa has been an invited expert on long COVID in children for the Ontario Science Table as well as the Chief Science Advisor of Canada Task Force on post COVID-19 condition.

Dr. Feng Xie is a Professor and Health Economist at McMaster University. His research interests include health technology assessment, cost effectiveness analysis, and patient reported outcome measures for clinical and economic evaluations. He is also interested in assessing and incorporating cost effectiveness evidence in clinical guidelines and recommendations. He led the GRADE Guidance paper #23 on incorporating cost effectiveness evidence in clinical guidelines using the Evidence to Decision framework.

Dr. Feng Xie is a Professor and Health Economist at McMaster University. His research interests include health technology assessment, cost effectiveness analysis, and patient reported outcome measures for clinical and economic evaluations. He is also interested in assessing and incorporating cost effectiveness evidence in clinical guidelines and recommendations. He led the GRADE Guidance paper #23 on incorporating cost effectiveness evidence in clinical guidelines using the Evidence to Decision framework.

Dr. Mehdi Aloosh is a public health and preventive medicine specialist and a family physician with extensive clinical and academic experience both internationally and in Canada. Currently, he is serving as the Medical Officer of Health for Windsor and Essex County, Ontario, Canada, where he oversees a population of approximately 450,000. In addition to his public health leadership role, Dr. Aloosh is an Assistant Professor at McMaster University and is actively involved in research and teaching. 

Dr. Mehdi Aloosh is a public health and preventive medicine specialist and a family physician with extensive clinical and academic experience both internationally and in Canada. Currently, he is serving as the Medical Officer of Health for Windsor and Essex County, Ontario, Canada, where he oversees a population of approximately 450,000. In addition to his public health leadership role, Dr. Aloosh is an Assistant Professor at McMaster University and is actively involved in research and teaching. 

Liimiiuum Hala’ayt (Singing Shaman) is two-spirit and of both Indigenous (Gitga’at – Ts’msyen) and Settler (Norwegian) background and is guided by the teachings of their ancestors. Their positive and personal cultural identity and knowledge have contributed to facilitating innovative and inclusive learning spaces in both K-12 and post-secondary education for over twenty-five years. Robert is passionate about learning and teaching; their commitment to improving the lives of those who they are in-service to is what drives them. This is evident in their approaches that honour: relationships, respect, reciprocity, relevance and responsibility. Robert is an active contributor to systemic transformation and provides guidance and consultation to many professional bodies and institutions.

Liimiiuum Hala’ayt (Singing Shaman) is two-spirit and of both Indigenous (Gitga’at – Ts’msyen) and Settler (Norwegian) background and is guided by the teachings of their ancestors. Their positive and personal cultural identity and knowledge have contributed to facilitating innovative and inclusive learning spaces in both K-12 and post-secondary education for over twenty-five years. Robert is passionate about learning and teaching; their commitment to improving the lives of those who they are in-service to is what drives them. This is evident in their approaches that honour: relationships, respect, reciprocity, relevance and responsibility. Robert is an active contributor to systemic transformation and provides guidance and consultation to many professional bodies and institutions.

Dr. Juthaporn Cowan is an Associate Professor at the University of Ottawa, specializing in infectious diseases. She leads the Ontario Immunoglobulin Treatment Program and co-leads the Canadian Immunization Research Network’s Special Immunization Clinic Network. Her expertise encompasses infection prevention in immunocompromised individuals, COVID-19 patient care, vaccine guidance, managing adverse events, and evaluating persistent post-COVID symptoms. As a co-investigator in the CANCOV and RECLAIM studies, she contributes to understanding and managing post-COVID conditions.

Dr. Juthaporn Cowan is an Associate Professor at the University of Ottawa, specializing in infectious diseases. She leads the Ontario Immunoglobulin Treatment Program and co-leads the Canadian Immunization Research Network’s Special Immunization Clinic Network. Her expertise encompasses infection prevention in immunocompromised individuals, COVID-19 patient care, vaccine guidance, managing adverse events, and evaluating persistent post-COVID symptoms. As a co-investigator in the CANCOV and RECLAIM studies, she contributes to understanding and managing post-COVID conditions.

Dr. Darzi is an Assistant Professor in the Departments of HEI and Anesthesia at McMaster University and an Associate Convenor of the Campbell and Cochrane Health Equity Thematic Group. She previously held the role of Assistant Director of the AUB GRADE centre. She is a health research methodologist with over 10 years of experience in guideline development and adaptation; leading and contributing to efforts for Canada, WHO, the European commission, ministries of health, and academic institutions in the EMR, American Society of Hematology, and American Epilepsy Society.

Dr. Darzi is an Assistant Professor in the Departments of HEI and Anesthesia at McMaster University and an Associate Convenor of the Campbell and Cochrane Health Equity Thematic Group. She previously held the role of Assistant Director of the AUB GRADE centre. She is a health research methodologist with over 10 years of experience in guideline development and adaptation; leading and contributing to efforts for Canada, WHO, the European commission, ministries of health, and academic institutions in the EMR, American Society of Hematology, and American Epilepsy Society.

Dr. Vinita Dubey is an Associate Medical Officer of Health for Toronto Public Health specializing with the Vaccine Preventable Disease program. She also works as an emergency medicine physician outside the GTA. She holds an Adjunct Professor appointment with the University of Toronto’s Dalla Lana School of Public Health. 

Dr. Vinita Dubey is an Associate Medical Officer of Health for Toronto Public Health specializing with the Vaccine Preventable Disease program. She also works as an emergency medicine physician outside the GTA. She holds an Adjunct Professor appointment with the University of Toronto’s Dalla Lana School of Public Health. 

Dr. Fatima Fazalullasha is a Family Medicine Physician in Scarborough, Ontario with clinical interests in metabolic health, healthy aging, AI in medicine, and post-COVID-19 conditions. She was also a physician lead on the Toronto Public Health COVID-19 Response Team, working with institutional stakeholders on multidisciplinary teams to support policy development and outbreak management across the city in 150+ Long-Term Care and Retirement Homes, and also in child and youth settings. She completed her Bachelor of Health Sciences degree at McMaster University, her medical degree at the University of Ottawa, and her Family Medicine Residency at the University of Toronto.

Dr. Fatima Fazalullasha is a Family Medicine Physician in Scarborough, Ontario with clinical interests in metabolic health, healthy aging, AI in medicine, and post-COVID-19 conditions. She was also a physician lead on the Toronto Public Health COVID-19 Response Team, working with institutional stakeholders on multidisciplinary teams to support policy development and outbreak management across the city in 150+ Long-Term Care and Retirement Homes, and also in child and youth settings. She completed her Bachelor of Health Sciences degree at McMaster University, her medical degree at the University of Ottawa, and her Family Medicine Residency at the University of Toronto.

Carolyn Gosse is a Regional Professional Practice Consultant with Newfoundland and Labrador Health Services with primary responsibility for Community, Primary and Public HeXalth Programs. She has practiced in the community setting as a frontline RN, Clinical Educator, and Program Manager and received Certification in Community Health Nursing from Canadian Nurses Association in 2015.

Carolyn Gosse is a Regional Professional Practice Consultant with Newfoundland and Labrador Health Services with primary responsibility for Community, Primary and Public HeXalth Programs. She has practiced in the community setting as a frontline RN, Clinical Educator, and Program Manager and received Certification in Community Health Nursing from Canadian Nurses Association in 2015.

Dr. Jessica Hopkins is a public health and preventive medicine physician with significant local and provincial public health expertise. As the Chief Health Protection and Emergency Preparedness Officer at Public Health Ontario, she leads a multi-disciplinary team in analyzing data and evidence to advise decision-makers on public health and infection control programs. Dr. Hopkins has previously served as the Medical Officer of Health (MOH) for Peel Region, Associate MOH in Hamilton and Niagara Region, and is a practicing family doctor. She is an Associate Professor at McMaster University and an Adjunct Lecturer at the Dalla Lana School of Public Health, University of Toronto.

Dr. Jessica Hopkins is a public health and preventive medicine physician with significant local and provincial public health expertise. As the Chief Health Protection and Emergency Preparedness Officer at Public Health Ontario, she leads a multi-disciplinary team in analyzing data and evidence to advise decision-makers on public health and infection control programs. Dr. Hopkins has previously served as the Medical Officer of Health (MOH) for Peel Region, Associate MOH in Hamilton and Niagara Region, and is a practicing family doctor. She is an Associate Professor at McMaster University and an Adjunct Lecturer at the Dalla Lana School of Public Health, University of Toronto.

Dr. Jennifer Hulme, an Emergency and Addictions Physician at University Health Network (UHN), is an Assistant Professor at the University of Toronto. Her early career emphasized enhancing primary care globally, particularly in reproductive, maternal, and child health across multiple countries. She co-led an operations research project in Mozambique on misoprostol’s use to prevent postpartum hemorrhage. As the UHN Emergency Department’s Health Equity co-lead and Board Chair for the Centre for Global Equity in Emergency Medicine, her research aims to tackle health disparities.

Dr. Jennifer Hulme, an Emergency and Addictions Physician at University Health Network (UHN), is an Assistant Professor at the University of Toronto. Her early career emphasized enhancing primary care globally, particularly in reproductive, maternal, and child health across multiple countries. She co-led an operations research project in Mozambique on misoprostol’s use to prevent postpartum hemorrhage. As the UHN Emergency Department’s Health Equity co-lead and Board Chair for the Centre for Global Equity in Emergency Medicine, her research aims to tackle health disparities.

Dr. Peters is an Assistant Professor (Partner) in the School of Population and Public Health at the University of British Columbia, Senior Scientist at the BC Center for Disease Control in Population and Public Health, and Scientific Director of Prevention, Screening and Hereditary Cancer at BC Cancer. She is an international expert in chronic disease prevention, particularly the prevention of occupational diseases. She is trained in occupational and environmental hygiene (MSc) as well as epidemiology and public health (PhD).

Dr. Peters is an Assistant Professor (Partner) in the School of Population and Public Health at the University of British Columbia, Senior Scientist at the BC Center for Disease Control in Population and Public Health, and Scientific Director of Prevention, Screening and Hereditary Cancer at BC Cancer. She is an international expert in chronic disease prevention, particularly the prevention of occupational diseases. She is trained in occupational and environmental hygiene (MSc) as well as epidemiology and public health (PhD).

Dr. Thomas Piggott is the Medical Officer of Health and CEO at Peterborough Public Health, also serving as an Assistant Professor at McMaster University and Queens University. With a background in public health, he has worked at various levels in Canada and internationally. He previously worked as MOH and VP lead for Population/Rural & Remote Health in Labrador and with Doctors Without Borders in the Democratic Republic of the Congo. He is actively involved in research, teaching, clinical work, and is a father of young children.

Dr. Thomas Piggott is the Medical Officer of Health and CEO at Peterborough Public Health, also serving as an Assistant Professor at McMaster University and Queens University. With a background in public health, he has worked at various levels in Canada and internationally. He previously worked as MOH and VP lead for Population/Rural & Remote Health in Labrador and with Doctors Without Borders in the Democratic Republic of the Congo. He is actively involved in research, teaching, clinical work, and is a father of young children.

Dr. Thavorn is a Senior Scientist and Health Economist at the Ottawa Hospital Research Institute. Additionally, she’s an Associate Professor at the University of Ottawa’s School of Epidemiology and Public Health and serves as an Adjunct Scientist at ICES. Her research delves into health economics, health technology assessment (HTA), pharmacoepidemiology, health equity, care for complex needs, and population health. Dr. Thavorn collaborates on national and international health services research, aiming to optimize resources and enhance care quality. Her contributions were recognized with the 2023 CADTH Dr. Maurice McGregor Award for emerging talents in HTA.

Dr. Thavorn is a Senior Scientist and Health Economist at the Ottawa Hospital Research Institute. Additionally, she’s an Associate Professor at the University of Ottawa’s School of Epidemiology and Public Health and serves as an Adjunct Scientist at ICES. Her research delves into health economics, health technology assessment (HTA), pharmacoepidemiology, health equity, care for complex needs, and population health. Dr. Thavorn collaborates on national and international health services research, aiming to optimize resources and enhance care quality. Her contributions were recognized with the 2023 CADTH Dr. Maurice McGregor Award for emerging talents in HTA.

Dr. Vasquez Camargo is a Family Physician, Clinical Assistant Professor, and the “Caring with Evidence Curriculum” provincial coordinator at the University of Saskatchewan. She holds a Master of Science degree and leads projects on Long COVID Learning Needs Assessment and PCC Clinical Pathway in Saskatchewan as a member of the Long COVID advisory working group at Saskatchewan Health Authority. She is actively involved in various working groups, including the Guideline and Knowledge Translation Expert Working Group, and the Section of Researchers part of the College of Family Physicians of Canada and the SAKS Guidelines Provincial Committee.

Dr. Vasquez Camargo is a Family Physician, Clinical Assistant Professor, and the “Caring with Evidence Curriculum” provincial coordinator at the University of Saskatchewan. She holds a Master of Science degree and leads projects on Long COVID Learning Needs Assessment and PCC Clinical Pathway in Saskatchewan as a member of the Long COVID advisory working group at Saskatchewan Health Authority. She is actively involved in various working groups, including the Guideline and Knowledge Translation Expert Working Group, and the Section of Researchers part of the College of Family Physicians of Canada and the SAKS Guidelines Provincial Committee.

Dr. Brignardello-Petersen is an Associate Professor and the Associate Chair, Education, at the Department of Health Research Methods, Evidence, and Impact, at McMaster University. Her research and teaching focus on the development and application of methods for evidence synthesis and guideline development. She has worked as a guideline methodologist for several groups and organizations, including the World Health Organization, the Pan American Health Organization, and the American Society of Hematology.

Dr. Brignardello-Petersen is an Associate Professor and the Associate Chair, Education, at the Department of Health Research Methods, Evidence, and Impact, at McMaster University. Her research and teaching focus on the development and application of methods for evidence synthesis and guideline development. She has worked as a guideline methodologist for several groups and organizations, including the World Health Organization, the Pan American Health Organization, and the American Society of Hematology.

Heather has over 20 years of experience in Municipal Recreation program delivery within a supervisory capacity, overseeing multiple sites. She is passionate about culture building, the importance of team dynamics, continual growth, and providing exceptional customer service. She has instructed a variety of leadership courses in the last 25 years. Currently navigating her own Post COVID Condition, Heather educates and advocates for herself and others.

Heather has over 20 years of experience in Municipal Recreation program delivery within a supervisory capacity, overseeing multiple sites. She is passionate about culture building, the importance of team dynamics, continual growth, and providing exceptional customer service. She has instructed a variety of leadership courses in the last 25 years. Currently navigating her own Post COVID Condition, Heather educates and advocates for herself and others.

Dr. Falcone is the Director of the IRCM Post-COVID-19 Research Clinic and Microbiome and Mucosal Defence Research Unit at the Montreal Clinical Research Institute (IRCM). She is an Assistant Clinical Professor at Université de Montréal, holding a Tier 2 Canada Research Chair in the Role of the Microbiome in Primary Immunodeficiency. As a pioneer during the pandemic, she established the first long COVID research clinic in Quebec, clinically evaluating hundreds of individuals with long COVID while investigating the pathophysiological mechanisms underlying post-COVID-19 conditions. Dr. Falcone actively contributes to provincial and federal long COVID initiatives, co-chaired Canada’s first long COVID research symposium, and plays leadership roles in several research committees and networks.

Dr. Falcone is the Director of the IRCM Post-COVID-19 Research Clinic and Microbiome and Mucosal Defence Research Unit at the Montreal Clinical Research Institute (IRCM). She is an Assistant Clinical Professor at Université de Montréal, holding a Tier 2 Canada Research Chair in the Role of the Microbiome in Primary Immunodeficiency. As a pioneer during the pandemic, she established the first long COVID research clinic in Quebec, clinically evaluating hundreds of individuals with long COVID while investigating the pathophysiological mechanisms underlying post-COVID-19 conditions. Dr. Falcone actively contributes to provincial and federal long COVID initiatives, co-chaired Canada’s first long COVID research symposium, and plays leadership roles in several research committees and networks.

Dr. Kamrul is a Family Physician and Associate Professor in the Regina Academic Family Medicine unit at the University of Saskatchewan. She is a recipient of the Fellowship of the College of Family Physicians of Canada (FCFP). Her research focuses on the development of evidence-informed health care with community involvement with a special interest in immigrants and refugee health , chronic diseases, and mental health. Dr. Kamrul actively contributes to both undergraduate and postgraduate medical education, and continuous development of curriculum for family medicine residents and students. She is a member of the long COVID advisory working group at Saskatchewan Health Authority.

Dr. Kamrul is a Family Physician and Associate Professor in the Regina Academic Family Medicine unit at the University of Saskatchewan. She is a recipient of the Fellowship of the College of Family Physicians of Canada (FCFP). Her research focuses on the development of evidence-informed health care with community involvement with a special interest in immigrants and refugee health , chronic diseases, and mental health. Dr. Kamrul actively contributes to both undergraduate and postgraduate medical education, and continuous development of curriculum for family medicine residents and students. She is a member of the long COVID advisory working group at Saskatchewan Health Authority.

Dr. Lam is a clinician scientist and assistant professor in the Division of Pulmonary Medicine at the University of Alberta. She is the co-founder and co-director of one of the first post COVID-19 clinics in Canada. Dr. Lam has published papers on exploring risk factors for long COVID and leads or is involved in numerous local and national long COVID projects, funded by industry (Roche Diagnostics), local (Alberta Lung), and national grants (CIHR). Her innovative work earned her recognition as one of the Top 40 under 40 by Edify Magazine.

Dr. Lam is a clinician scientist and assistant professor in the Division of Pulmonary Medicine at the University of Alberta. She is the co-founder and co-director of one of the first post COVID-19 clinics in Canada. Dr. Lam has published papers on exploring risk factors for long COVID and leads or is involved in numerous local and national long COVID projects, funded by industry (Roche Diagnostics), local (Alberta Lung), and national grants (CIHR). Her innovative work earned her recognition as one of the Top 40 under 40 by Edify Magazine.

Candace McNaughton is a Scientist at Sunnybrook Research Institute and Associate Professor in Department of Medicine at the University of Toronto. Dr. McNaughton’s research in heart failure, hypertension, and long COVID includes validation of mass spectrometry to measure serum concentrations of cardiovascular medications; survey design and validation, implementation science, clinical trials and health services research.

Candace McNaughton is a Scientist at Sunnybrook Research Institute and Associate Professor in Department of Medicine at the University of Toronto. Dr. McNaughton’s research in heart failure, hypertension, and long COVID includes validation of mass spectrometry to measure serum concentrations of cardiovascular medications; survey design and validation, implementation science, clinical trials and health services research.

Dr. Mustafa is a nephrologist with a master’s degree in public health and a PhD in Health Research Methodology/Clinical Epidemiology. She is a Professor of Internal Medicine/Nephrology at the University of Kansas Health System and the Director of the Outcomes and Implementation Research Unit. Dr. Mustafa’s research focuses on the application of principles of evidence-based medicine in clinical and public health decision-making, with a focus on diagnosis. She has extensive experience in the development and assessment of clinical practice guidelines through her work with The Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. Dr. Mustafa has been an advisor and chair of multiple guideline development groups internationally with the World Health Organization (WHO), the Infectious Disease Society of America (IDSA), the American Society of Hematology (ASH), Kidney Disease Improving Global Outcomes (KDIGO) guidelines, The Canadian Society of Nephrology (CSN), among others. She is a co-founder of the U.S. GRADE network and the Evidence Foundation and has published more than 300 peer-reviewed publications. Dr. Mustafa has been recognized as one of the “true pioneers in their fields over the last decade demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in the Web of Science™.

Dr. Mustafa is a nephrologist with a master’s degree in public health and a PhD in Health Research Methodology/Clinical Epidemiology. She is a Professor of Internal Medicine/Nephrology at the University of Kansas Health System and the Director of the Outcomes and Implementation Research Unit. Dr. Mustafa’s research focuses on the application of principles of evidence-based medicine in clinical and public health decision-making, with a focus on diagnosis. She has extensive experience in the development and assessment of clinical practice guidelines through her work with The Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. Dr. Mustafa has been an advisor and chair of multiple guideline development groups internationally with the World Health Organization (WHO), the Infectious Disease Society of America (IDSA), the American Society of Hematology (ASH), Kidney Disease Improving Global Outcomes (KDIGO) guidelines, The Canadian Society of Nephrology (CSN), among others. She is a co-founder of the U.S. GRADE network and the Evidence Foundation and has published more than 300 peer-reviewed publications. Dr. Mustafa has been recognized as one of the “true pioneers in their fields over the last decade demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in the Web of Science™.

Dr. Gavin Oudit is a Professor, Staff Cardiologist, and Clinician-Scientist at the Mazankowski Alberta Heart Institute, University of Alberta. He completed his BSc, MSc, and MD studies at the University of Toronto, followed by training in Internal Medicine, Clinician-Investigator Program (PhD), and Adult Cardiology. His clinical activity focuses on heart failure and cardiomyopathies, while his research interests lie in heart failure, cardiomyopathies, novel therapeutics, and COVID-19. Dr. Oudit currently holds a Canada Research Chair in Heart Failure, serves as the Director of the Heart Function Clinic, is a Fellow of the Canadian Academy of Health Sciences, and is a Member of the Long COVID Web.

Dr. Gavin Oudit is a Professor, Staff Cardiologist, and Clinician-Scientist at the Mazankowski Alberta Heart Institute, University of Alberta. He completed his BSc, MSc, and MD studies at the University of Toronto, followed by training in Internal Medicine, Clinician-Investigator Program (PhD), and Adult Cardiology. His clinical activity focuses on heart failure and cardiomyopathies, while his research interests lie in heart failure, cardiomyopathies, novel therapeutics, and COVID-19. Dr. Oudit currently holds a Canada Research Chair in Heart Failure, serves as the Director of the Heart Function Clinic, is a Fellow of the Canadian Academy of Health Sciences, and is a Member of the Long COVID Web.

Dr. Piché is a microbiologist and an infectious disease specialist at the CIUSSSE-CHUS. He is the medical director of the post-COVID-19 clinic that he founded in March 2020.  In that context, he has seen hundreds of patients with long COVID. He is a professor in the department microbiology and infectious diseases at Université de Sherbrooke. Dr Piché is actively involved in various provincial and federal advisory boards, research committees, networks, and biobanking efforts associated with long COVID. Research interests in long COVID focusses on long term consequences, immunology, and biomarkers. He is involved in several clinical trials for long COVID treatments. He has published over 100 peer-reviewed manuscripts, including 10 related to COVID-19.

Dr. Piché is a microbiologist and an infectious disease specialist at the CIUSSSE-CHUS. He is the medical director of the post-COVID-19 clinic that he founded in March 2020.  In that context, he has seen hundreds of patients with long COVID. He is a professor in the department microbiology and infectious diseases at Université de Sherbrooke. Dr Piché is actively involved in various provincial and federal advisory boards, research committees, networks, and biobanking efforts associated with long COVID. Research interests in long COVID focusses on long term consequences, immunology, and biomarkers. He is involved in several clinical trials for long COVID treatments. He has published over 100 peer-reviewed manuscripts, including 10 related to COVID-19.

Dr. Vasquez Camargo is a Family Physician, Clinical Assistant Professor, and the “Caring with Evidence Curriculum” provincial coordinator at the University of Saskatchewan. She holds a Master of Science degree and leads projects on Long COVID Learning Needs Assessment and PCC Clinical Pathway in Saskatchewan as a member of the Long COVID advisory working group at Saskatchewan Health Authority. She is actively involved in various working groups, including the Guideline and Knowledge Translation Expert Working Group, and the Section of Researchers part of the College of Family Physicians of Canada and the SAKS Guidelines Provincial Committee.

Dr. Vasquez Camargo is a Family Physician, Clinical Assistant Professor, and the “Caring with Evidence Curriculum” provincial coordinator at the University of Saskatchewan. She holds a Master of Science degree and leads projects on Long COVID Learning Needs Assessment and PCC Clinical Pathway in Saskatchewan as a member of the Long COVID advisory working group at Saskatchewan Health Authority. She is actively involved in various working groups, including the Guideline and Knowledge Translation Expert Working Group, and the Section of Researchers part of the College of Family Physicians of Canada and the SAKS Guidelines Provincial Committee.

Stacey Alexander, an educator in Newfoundland & Labrador, holds degrees in Physical Education, Education, and a Masters in Education (Information Technology) from Memorial and St. Thomas Universities. Developing PCC in early 2020, she’s actively involved in ongoing post-COVID research and advocates for those with PCC/Long Covid. She is a member of the admin team for the social media support group, Long Covid Canada. Stacey contributes to the Pharmacological & nonpharmacological clinical interventions for PCC Guideline team and the Equity Oversight Committee.

Stacey Alexander, an educator in Newfoundland & Labrador, holds degrees in Physical Education, Education, and a Masters in Education (Information Technology) from Memorial and St. Thomas Universities. Developing PCC in early 2020, she’s actively involved in ongoing post-COVID research and advocates for those with PCC/Long Covid. She is a member of the admin team for the social media support group, Long Covid Canada. Stacey contributes to the Pharmacological & nonpharmacological clinical interventions for PCC Guideline team and the Equity Oversight Committee.

Dr. Beauchamp is a physical therapist and Associate Professor in the School of Rehabilitation Sciences at McMaster University. She is also the Associate Scientific Director of the MIRA | Dixon Hall Centre in Toronto. Dr. Beauchamp holds a tier 2 Canada Research Chair in Mobility, Aging and Chronic Disease and an Early Researcher Award from the Ontario Ministry of Colleges and Universities. The overarching aim of her research is to identify ways to improve mobility in later life. Her research leadership extends to interdisciplinary projects on fall risk assessment and prevention, wearable technology for mobility monitoring, and studies on recovery after COVID-19.

Dr. Beauchamp is a physical therapist and Associate Professor in the School of Rehabilitation Sciences at McMaster University. She is also the Associate Scientific Director of the MIRA | Dixon Hall Centre in Toronto. Dr. Beauchamp holds a tier 2 Canada Research Chair in Mobility, Aging and Chronic Disease and an Early Researcher Award from the Ontario Ministry of Colleges and Universities. The overarching aim of her research is to identify ways to improve mobility in later life. Her research leadership extends to interdisciplinary projects on fall risk assessment and prevention, wearable technology for mobility monitoring, and studies on recovery after COVID-19.

Jill Cameron is a professor, and also co-directs the Rehabilitation Science Research Network for COVID in the Temerty Faculty of Medicine. Serving as Co-Chair of both the Transition Guidelines for the Canada Stroke Best Practice Recommendations from 2014 to 2019 and Long COVID Web (Clinical Pillar 2), Jill has over 100 publications and over $37 million in research funding. Her primary research interest is to understand the experiences and needs of family members who assume the role of caregiver for individuals with disability, striving to enhance models of health care delivery to support caregivers across the care continuum.

Jill Cameron is a professor, and also co-directs the Rehabilitation Science Research Network for COVID in the Temerty Faculty of Medicine. Serving as Co-Chair of both the Transition Guidelines for the Canada Stroke Best Practice Recommendations from 2014 to 2019 and Long COVID Web (Clinical Pillar 2), Jill has over 100 publications and over $37 million in research funding. Her primary research interest is to understand the experiences and needs of family members who assume the role of caregiver for individuals with disability, striving to enhance models of health care delivery to support caregivers across the care continuum.

Jaymie Firkus is a Multimedia Designer and Marketing professional and creator of Long Covid Canada Resources, an online grassroots initiative providing those living in Canada with the latest research, resources and supports available to them. As a patient advocate, Jaymie has contributed to the CIHR, CADTH as well as the CAN-PCC in efforts to ensure that the voices and needs of individuals living with Long Covid and its related post-infection conditions are not only heard, but also addressed in the development of future healthcare policies and research agendas

Jaymie Firkus is a Multimedia Designer and Marketing professional and creator of Long Covid Canada Resources, an online grassroots initiative providing those living in Canada with the latest research, resources and supports available to them. As a patient advocate, Jaymie has contributed to the CIHR, CADTH as well as the CAN-PCC in efforts to ensure that the voices and needs of individuals living with Long Covid and its related post-infection conditions are not only heard, but also addressed in the development of future healthcare policies and research agendas

Douglas Gross serves as a professor and the chair of the Department of Physical Therapy at the University of Alberta, in addition to directing the Rehabilitation Research Centre. His scholarship focuses on preventing work disability. He has published over 150 articles and contributed to funded research projects totalling over $28 million, including projects funded by the Canadian Institutes of Health Research, WorkSafeBC, Alberta Labour and Immigration, among others. He is a Killam Laureate, McCalla Professor, and Editor-in-Chief of the Journal of Occupational Rehabilitation.

Douglas Gross serves as a professor and the chair of the Department of Physical Therapy at the University of Alberta, in addition to directing the Rehabilitation Research Centre. His scholarship focuses on preventing work disability. He has published over 150 articles and contributed to funded research projects totalling over $28 million, including projects funded by the Canadian Institutes of Health Research, WorkSafeBC, Alberta Labour and Immigration, among others. He is a Killam Laureate, McCalla Professor, and Editor-in-Chief of the Journal of Occupational Rehabilitation.

Dr. Thao Huynh, an associate professor of Medicine at McGill University Health Center, is a cardiologist and epidemiologist with interests in knowledge mobilization, post-COVID condition, and health disparities. With over 200 peer-reviewed publications, she currently leads the IMPACT-QUEBEC COVID-19 project, a prospective cohort of 400 patients with Post-COVID Conditions supported by Pfizer Inc. Additionally, she co-authored the guidelines for treating myocardial infarction in Canada (2008 and 2019) and served as a consultant for the Agency of Evaluation of Technology of Quebec (AETMIS: 2006-2008).

Dr. Thao Huynh, an associate professor of Medicine at McGill University Health Center, is a cardiologist and epidemiologist with interests in knowledge mobilization, post-COVID condition, and health disparities. With over 200 peer-reviewed publications, she currently leads the IMPACT-QUEBEC COVID-19 project, a prospective cohort of 400 patients with Post-COVID Conditions supported by Pfizer Inc. Additionally, she co-authored the guidelines for treating myocardial infarction in Canada (2008 and 2019) and served as a consultant for the Agency of Evaluation of Technology of Quebec (AETMIS: 2006-2008).

Dr. Janaudis-Ferreira is an Associate Professor with the School of Physical and Occupational Therapy at McGill University and a Scientist with the Research Institute of the McGill University Health Centre in Montreal, Canada. She has been awarded several national grants as principal investigator from the Canadian Institutes of Health Research, Quebec Respiratory Health Network, Canadian Lung Association, Kidney Foundation of Canada, Canadian Society of transplantation, and Canadian Donation and Transplantation Research Program. She is currently leading a trial on virtual rehabilitation for individuals with long COVID.

Dr. Janaudis-Ferreira is an Associate Professor with the School of Physical and Occupational Therapy at McGill University and a Scientist with the Research Institute of the McGill University Health Centre in Montreal, Canada. She has been awarded several national grants as principal investigator from the Canadian Institutes of Health Research, Quebec Respiratory Health Network, Canadian Lung Association, Kidney Foundation of Canada, Canadian Society of transplantation, and Canadian Donation and Transplantation Research Program. She is currently leading a trial on virtual rehabilitation for individuals with long COVID.

Dr. Lam is a clinician scientist and assistant professor in the Division of Pulmonary Medicine at the University of Alberta. She is the co-founder and co-director of one of the first post COVID-19 clinics in Canada. Dr. Lam has published papers on exploring risk factors for long COVID and leads or is involved in numerous local and national long COVID projects, funded by industry (Roche Diagnostics), local (Alberta Lung), and national grants (CIHR). Her innovative work earned her recognition as one of the Top 40 under 40 by Edify Magazine.

Dr. Lam is a clinician scientist and assistant professor in the Division of Pulmonary Medicine at the University of Alberta. She is the co-founder and co-director of one of the first post COVID-19 clinics in Canada. Dr. Lam has published papers on exploring risk factors for long COVID and leads or is involved in numerous local and national long COVID projects, funded by industry (Roche Diagnostics), local (Alberta Lung), and national grants (CIHR). Her innovative work earned her recognition as one of the Top 40 under 40 by Edify Magazine.

Louise Lemay is living with long covid since December 2021. She caught it when she was pregnant and she was hospitalized.  Since then, she is still having lingering symptoms affecting of everyday life including her working capacity.  Prior to her illness, she was a family doctor in Montreal, Canada. Since her graduation in Family Medicine from University of Montreal in 2011, she had various fields of practice including Emergency Medicine, International Health and Family medicine clinics. She also has been active in teaching for healthcare providers in both University of Montreal and University of Sherbrooke. 

Louise Lemay is living with long covid since December 2021. She caught it when she was pregnant and she was hospitalized.  Since then, she is still having lingering symptoms affecting of everyday life including her working capacity.  Prior to her illness, she was a family doctor in Montreal, Canada. Since her graduation in Family Medicine from University of Montreal in 2011, she had various fields of practice including Emergency Medicine, International Health and Family medicine clinics. She also has been active in teaching for healthcare providers in both University of Montreal and University of Sherbrooke. 

Grigorios Leontiadis is a Professor in the Department of Medicine at McMaster University, Canada. He is a member of the GRADE Working Group, Joint Coordinating Editor of the Gut Cochrane Group, Special Section Editor (Methodology and Guidelines ) for Gastroenterology, and VP of Clinical Affairs at the Canadian Association of Gastroenterology. He has worked with several professional societies in the development of clinical practice guidelines as lead methodologist or content expert and has led multiple systematic reviews. He has taught virtual and in-person workshops on systematic review and guideline methods. He is an author of over 100 peer-reviewed publications (h-index 50 in Google Scholar).

Grigorios Leontiadis is a Professor in the Department of Medicine at McMaster University, Canada. He is a member of the GRADE Working Group, Joint Coordinating Editor of the Gut Cochrane Group, Special Section Editor (Methodology and Guidelines ) for Gastroenterology, and VP of Clinical Affairs at the Canadian Association of Gastroenterology. He has worked with several professional societies in the development of clinical practice guidelines as lead methodologist or content expert and has led multiple systematic reviews. He has taught virtual and in-person workshops on systematic review and guideline methods. He is an author of over 100 peer-reviewed publications (h-index 50 in Google Scholar).

Dr. Naik is a General Internal Medicine physician and Research Fellow with the Post-COVID-19 Interdisciplinary Clinical Care Network (PC-ICCN) in British Columbia. He is enrolled in the Clinician Investigator Program at the University of British Columbia and is concurrently completing a Masters of Science from the Harvard T.H. Chan School of Public Health. He has an interest in research that examines treatments and care pathways for patients with PCC.

Dr. Naik is a General Internal Medicine physician and Research Fellow with the Post-COVID-19 Interdisciplinary Clinical Care Network (PC-ICCN) in British Columbia. He is enrolled in the Clinician Investigator Program at the University of British Columbia and is concurrently completing a Masters of Science from the Harvard T.H. Chan School of Public Health. He has an interest in research that examines treatments and care pathways for patients with PCC.

Kelly O’Brien, a Professor in the Department of Physical Therapy and a Canada Research Chair (Tier 2) in Episodic Disability and Rehabilitation specializing in episodic disability, chronic disease, and rehabilitation, focuses on characterizing and measuring episodic disability. Using HIV and Long COVID as models, she investigates community-based rehabilitation interventions to enhance health outcomes for those with chronic conditions. In addition to being a member of Long COVID Physio, Kelly co-founded the Canada-International HIV and Rehabilitation Research Collaborative and serves on the Board of Directors for the Canadian Association for HIV Research.

Kelly O’Brien, a Professor in the Department of Physical Therapy and a Canada Research Chair (Tier 2) in Episodic Disability and Rehabilitation specializing in episodic disability, chronic disease, and rehabilitation, focuses on characterizing and measuring episodic disability. Using HIV and Long COVID as models, she investigates community-based rehabilitation interventions to enhance health outcomes for those with chronic conditions. In addition to being a member of Long COVID Physio, Kelly co-founded the Canada-International HIV and Rehabilitation Research Collaborative and serves on the Board of Directors for the Canadian Association for HIV Research.

Dr. Quinn, a General Internist and Palliative Care Clinician-Scientist at Sinai Health, focuses on enhancing end-of-life care for people with non-cancer terminal illnesses such as heart failure and dementia. As an Adjunct Scientist at ICES, he employs advanced analytic methods using administrative data to improve access and delivery of high-quality care. Dr. Quinn’s research also addresses the recognition and care of people with post-COVID-19 conditions. Recognized with the Governor General’s Gold Medal and the John Charles Polanyi Prize, he has published over 80 peer-reviewed articles in high-impact journals like JAMA and BMJ, along with securing over $27 million in grant funding.

Dr. Quinn, a General Internist and Palliative Care Clinician-Scientist at Sinai Health, focuses on enhancing end-of-life care for people with non-cancer terminal illnesses such as heart failure and dementia. As an Adjunct Scientist at ICES, he employs advanced analytic methods using administrative data to improve access and delivery of high-quality care. Dr. Quinn’s research also addresses the recognition and care of people with post-COVID-19 conditions. Recognized with the Governor General’s Gold Medal and the John Charles Polanyi Prize, he has published over 80 peer-reviewed articles in high-impact journals like JAMA and BMJ, along with securing over $27 million in grant funding.

Josée Séguin, Occupational Therapist and Director of Knowledge Translation Program at the Canadian Association of Occupational Therapists (CAOT) is responsible for national knowledge translation activities including CAOT conference, professional development, resources, publications (Canadian Journal of Occupational Therapy/ OT Now practice magazine) and initiatives such as Economic Evidence Clearinghouse, Promotion Occupational Participation textbook, Primary Care and Post COVID-19 Conditions. She has a Master’s in Rehabilitation Sciences (MSc) and is a doctoral candidate in Rehabilitation and Health Leadership (DScRHL) at Queen’s University.

Josée Séguin, Occupational Therapist and Director of Knowledge Translation Program at the Canadian Association of Occupational Therapists (CAOT) is responsible for national knowledge translation activities including CAOT conference, professional development, resources, publications (Canadian Journal of Occupational Therapy/ OT Now practice magazine) and initiatives such as Economic Evidence Clearinghouse, Promotion Occupational Participation textbook, Primary Care and Post COVID-19 Conditions. She has a Master’s in Rehabilitation Sciences (MSc) and is a doctoral candidate in Rehabilitation and Health Leadership (DScRHL) at Queen’s University.

Dr. Feng Xie is a Professor and Health Economist at McMaster University. His research interests include health technology assessment, cost effectiveness analysis, and patient reported outcome measures for clinical and economic evaluations. He is also interested in assessing and incorporating cost effectiveness evidence in clinical guidelines and recommendations. He led the GRADE Guidance paper #23 on incorporating cost effectiveness evidence in clinical guidelines using the Evidence to Decision framework.

Dr. Feng Xie is a Professor and Health Economist at McMaster University. His research interests include health technology assessment, cost effectiveness analysis, and patient reported outcome measures for clinical and economic evaluations. He is also interested in assessing and incorporating cost effectiveness evidence in clinical guidelines and recommendations. He led the GRADE Guidance paper #23 on incorporating cost effectiveness evidence in clinical guidelines using the Evidence to Decision framework.

Melissa Croskery, an Occupational Therapist with over 20 years of experience in Northern Canada, specializes in supporting children, youth, and their caregivers as well as teachers dealing with complex needs, such as neurodiversity and trauma. She was Regional Director of the North Chapter of the Canadian Association of Occupational Therapists for the past three years. Melissa also has lived experience with Long Covid and has worked in Northern Canada to support advocacy for those living with Post-Covid Condition, particularly those in rural and remote locations.

Melissa Croskery, an Occupational Therapist with over 20 years of experience in Northern Canada, specializes in supporting children, youth, and their caregivers as well as teachers dealing with complex needs, such as neurodiversity and trauma. She was Regional Director of the North Chapter of the Canadian Association of Occupational Therapists for the past three years. Melissa also has lived experience with Long Covid and has worked in Northern Canada to support advocacy for those living with Post-Covid Condition, particularly those in rural and remote locations.

Kimberly Flowers (B.Mgt.) is a champion of patient-empowered health care. She is a founding partner of the patient-led Head and Neck Cancer Support Society and involved in health research projects as a patient advocate, advisor and project-partner. Kimberly’s lived experience with post-Cancer and post-COVID conditions brings a unique lens to the project, in addition to her background in evaluation process and performance measures.

Kimberly Flowers (B.Mgt.) is a champion of patient-empowered health care. She is a founding partner of the patient-led Head and Neck Cancer Support Society and involved in health research projects as a patient advocate, advisor and project-partner. Kimberly’s lived experience with post-Cancer and post-COVID conditions brings a unique lens to the project, in addition to her background in evaluation process and performance measures.

Chris Maddison is an assistant professor in the Department of Computer Science and the Department of Statistical Sciences at the University of Toronto. He is a CIFAR AI Chair at the Vector Institute, a research scientist at DeepMind, a member of the ELLIS Society, and a faculty affiliate of the Schwartz Reisman Institute for Technology and Society. Maddison works on the methodology of statistical machine learning. 

Chris Maddison is an assistant professor in the Department of Computer Science and the Department of Statistical Sciences at the University of Toronto. He is a CIFAR AI Chair at the Vector Institute, a research scientist at DeepMind, a member of the ELLIS Society, and a faculty affiliate of the Schwartz Reisman Institute for Technology and Society. Maddison works on the methodology of statistical machine learning. 

Dr. Maxwell, with nearly two decades of expertise in systematic review and core outcome set methodology, held the role of Managing Editor at Cochrane Musculoskeletal for 19 years. Currently serving as a Senior Methodologist for both the Cochrane Health Equity Thematic Group and Outcome Measures in Rheumatology (OMERACT) at the University of Ottawa, Canada, her contributions include over 60 peer-reviewed publications.